<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094080</url>
  </required_header>
  <id_info>
    <org_study_id>502042</org_study_id>
    <nct_id>NCT01094080</nct_id>
  </id_info>
  <brief_title>Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health</brief_title>
  <acronym>BEMIM</acronym>
  <official_title>Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HiPP GmbH &amp; Co. Vertrieb KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the suitability of an infant formula with a modified content of protein and
      fatty acid pattern (LC-PUFA) for healthy term infants will be investigated.

      Primary hypothesis to be tested is: an infant formula with a modified protein content is non
      inferior compared to a standard infant formula in respect to the growth of healthy term
      infants.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of weight from day 30 to day 120</measure>
    <time_frame>postnatal age 30 to 120 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>anthropometry</measure>
    <time_frame>postnatal day 30, day 60, day 90, day 120 days</time_frame>
    <description>including body length, head circumference and derived parameter e.g. weight (from primary outcome) for length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood markers</measure>
    <time_frame>postnatal day 30, day 60, day 90, day 120 days (120 only)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up</measure>
    <time_frame>4 Years of age</time_frame>
    <description>At 4 Years of Age, an Interview Regarding Severe Events and Growth Since Study End Will be Performed and Anthropometric Data (Weight, Length, Head Circumference and Body Composition Measured Via Skinfolds and BIA) Will be Collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up at age 7 years with an interview regarding severe events and growth</measure>
    <time_frame>7 years of age</time_frame>
    <description>At 7 years of age we will perform anthropometric measurements (weight, height, head circumference and skinfolds) and bioimpedance measurement (from skinfolds and bioimpedance body composition will be estimated) additionally in an interview information on severe events (i.e. diseases) will be collected</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">505</enrollment>
  <condition>Infant Nutrition</condition>
  <arm_group>
    <arm_group_label>standard infant formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infants are fed a commercial formula during the first 4 month of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>modified infant formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants are fed a modified infant formula (modified protein content and fatty acid pattern) during the first 4 month of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>breast milk</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>infants are breast fed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard infant formula</intervention_name>
    <description>infants are fed a commercial formula</description>
    <arm_group_label>standard infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>modified infant formula</intervention_name>
    <description>the modified infant formula has a different protein content than the standard formula and long chain polyunsaturated fatty acids are added</description>
    <arm_group_label>modified infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>breast milk</intervention_name>
    <description>infants are breast fed</description>
    <arm_group_label>breast milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy term newborn

          -  gestational age between 37 and 41 weeks

          -  birth weight between the 3th and 97th weight-for-age percentile according to the
             EURO-Growth charts

          -  fully bottle-fed (at the latest with 28 days of age) or fully breast fed

          -  written parental informed consent

          -  Serbian nationality

        Exclusion Criteria:

          -  malformations, congenital heart defect, congenital vascular disease, severe diseases
             of gastrointestinal tract, kidney, liver, central nervous system and/or metabolic
             disease

          -  intensive care during first 14 days of life

          -  participation in any other clinical study intervention

          -  twins, multiple birth

          -  neonatal infection

          -  medication and parenteral nutrition

          -  metabolic disorders

          -  birth-related complications

          -  severe disturbances of neonatal adaption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Koletzko, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Hauner Children Hospital, Ludwig Maximilians Universität</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tatjana Nicolić Nicolić, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Gynecology and Obstretition of Clinical Center Belgrade</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hauner Childrens Hospital, LudwigMaximilans Universität</name>
      <address>
        <city>Muenchen</city>
        <zip>D-80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Gynecology and Obstretition of Clinical Center</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Serbia</country>
  </location_countries>
  <results_reference>
    <citation>Fleddermann M, Demmelmair H, Grote V, Nikolic T, Trisic B, Koletzko B. Infant formula composition affects energetic efficiency for growth: the BeMIM study, a randomized controlled trial. Clin Nutr. 2014 Aug;33(4):588-95. doi: 10.1016/j.clnu.2013.12.007. Epub 2013 Dec 30.</citation>
    <PMID>24411489</PMID>
  </results_reference>
  <results_reference>
    <citation>Fleddermann M, Demmelmair H, Grote V, Bidlingmaier M, Grimminger P, Bielohuby M, Koletzko B. Role of selected amino acids on plasma IGF-I concentration in infants. Eur J Nutr. 2017 Mar;56(2):613-620. doi: 10.1007/s00394-015-1105-9. Epub 2015 Nov 30.</citation>
    <PMID>26621633</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Prof. Berthold Koletzko</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>fully formula fed</keyword>
  <keyword>fully breast fed</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

